Improving quality of malaria treatment services: assessing inequities in consumers' perceptions and providers' behaviour in Nigeria.

Department of Health Administration and Management, College of Medicine, University of Nigeria, Enugu, Nigeria. .
International Journal for Equity in Health (Impact Factor: 1.71). 10/2010; 9:22. DOI: 10.1186/1475-9276-9-22
Source: PubMed

ABSTRACT Information about quality of malaria treatment services of different healthcare providers is needed to know how to improve the treatment of malaria since inappropriate service provision leads to increased burden of malaria. Hence, the study determined the technical and perceived quality of malaria treatment services of different types of providers in three urban and three rural areas in southeast Nigeria.
Questionnaire was used to interview randomly selected healthcare providers about the technical quality of their malaria treatment services. Exit polls were used to obtain information about perceived quality from consumers. A socio-economic status (SES) index and comparison of data between urban and rural areas was used to examine socio-economic status and geographic differences in quality of services.
The lowest technical quality of services was found from patent medicine dealers. Conversely, public and private hospitals as well as primary healthcare centres had the highest quality of services. Householders were least satisfied with quality of services of patent medicine dealers and pharmacy shops and were mostly satisfied with services rendered by public and private hospitals. The urbanites were more satisfied with the overall quality of services than the rural dwellers.
These findings provide areas for interventions to equitably improve the quality of malaria treatment services, especially for patent medicine dealers and pharmacy shops, that are two of the most common providers of malaria treatment especially with the current change of first line drugs from the relatively inexpensive drugs to the expensive artemisinin-based combination therapy, so as to decrease inappropriate drug prescribing, use, costs and resistance to artemisinin-based combination therapy.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Patent Medicine vendors (PMVs) can provide an opportunity for effective scaling up of artemsinin based combination therapy (ACT). However, there are serious concerns about their malaria treatment practices. Inadequate medicine sellers’ knowledge will likely jeopardise the objective of this combination therapy. It is therefore relevant to assess the knowledge and utilization of ACTs by the PMVs in communities in Nigeria. Objective: This study was conducted to evaluate the knowledge and utilization of artemisinin based combination therapy (ACT) by PMVs. Methodology: The study was conducted among PMVs in six (6) communities in Anambra state, South-east Nigeria. A minimal sample size of 237 was determined using the formula for descriptive studies and 270 PMVs were used for the study. An interviewer administered questionnaire was used for the data collection and the data analysed using Statistical Program for Social Sciences (SPSS) version 18. Results: Only 8 % of the respondents correctly mentioned the vector organism responsible for malaria transmission. However, while 78 % of the PMVs were conversant with the term ACT and 71 % stock ACT in their shops, only 13.3 % knew the Federal Ministry of Health (FMOH) recommended first line drug for treatment of uncomplicated malaria and also, only 23 % knew the distinction between mono- and combination therapies. Meanwhile, only 38.9 % of the interviewed group indicated paticipating in malaria trainings organised by different organisations in the past three years. Furthermore, 16.7 %, 20 % and 25.6 % respectively knew the dosage regimen, side effects and contra indications to a stated ACT.
    International Journal of Collaborative Research on Internal Medicine & Public Health. 01/2013; 5(10):619-629.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: • Research Quality of care for the treatment for uncomplicated malaria in South-East Nigeria: how important is socioeconomic status? Ogochukwu P Ibe1*, Lindsay Mangham-Jefferies2, Bonnie Cundill3, Virginia Wiseman2, Benjamin S Uzochukwu14 and Obinna E Onwujekwe15 • * Corresponding author: Ogochukwu P Ibe Author Affiliations For all author emails, please log on. International Journal for Equity in Health 2015, 14:19 doi:10.1186/s12939-015-0150-6 URL: Published: 14 February 2015 Abstract (provisional) Introduction: Ensuring equitable coverage of appropriate malaria treatment remains a high priority for the Nigerian government. This study examines the health seeking behaviour, patient-provider interaction and quality of care received by febrile patients of different socio-economic status (SES) groups. Methods: A total of 1642 febrile patients and caregivers exiting public health centres, pharmacies and patent medicine dealers were surveyed in Enugu state, South-East Nigeria to obtain information on treatment seeking behaviour, patient-provider interactions and treatment received. Socioeconomic status was estimated for each patient using exit survey data on household assets in combination with asset ownership data from the 2008 Nigeria Demographic and Health Survey. Results: Among the poorest SES group, 29% sought treatment at public health centres, 13% at pharmacies and 58% at patent medicine dealers (p?<?0.01). Very few of those in the richest SES group used public health centres (4%) instead choosing to go to pharmacies (44%) and patent medicine dealers (52%, p?<?0.001). During consultations with a healthcare provider, the poorest compared to the richest were significantly more likely to discuss symptoms with the provider, be physically examined and rely on providers for diagnosis and treatment rather than request a specific medicine. Those from the poorest SES group were however, least likely to request or to receive an antimalarial (p?<?0.001). The use of artemisinin combination therapy (ACT), the recommended treatment for uncomplicated malaria, was low across all SES groups. Conclusions: The quality of malaria treatment is sub-optimal for all febrile patients. Having greater interaction with the provider also did not translate to better quality care for the poor. The poor face a number of significant barriers to accessing quality treatment especially in relation to treatment seeking behaviour and type of treatment received. Strategies to address these inequities are fundamental to achieving universal coverage of effective malaria treatment and ensuring that the most vulnerable people are not left behind.
    International Journal for Equity in Health 02/2015; 14(19). · 1.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To reduce the burden of disease from malaria, innovative approaches are needed to engender behavior change. One unobservable, but fundamental trait--preferences for risk--may influence individuals' willingness to adopt new health technologies. We explore the association of risk preferences with malaria care-seeking behavior and the acceptability of malaria rapid diagnostic tests (RDTs) to inform RDT scale-up plans.
    BMC Health Services Research 09/2014; 14(1):374. · 1.66 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014